Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025
Penumbra (NYSE: PEN) has scheduled its fourth quarter and full year 2024 earnings release and conference call for February 18, 2025. The company will issue a press release detailing financial results after market close, followed by a conference call at 4:30 PM Eastern Time.
Investors can access the conference call by dialing (888) 596-4144 with conference ID 5872954, or join via webcast through the 'Events and Presentations' section on Penumbra's website. The webcast recording will remain available for at least two weeks after the call.
Penumbra (NYSE: PEN) ha programmato il rilascio dei risultati finanziari per il quarto trimestre e l'intero anno 2024 per il 18 febbraio 2025. L'azienda emetterà un comunicato stampa con i dettagli dei risultati finanziari dopo la chiusura del mercato, seguito da una conferenza telefonica alle 16:30 ora orientale.
Gli investitori possono partecipare alla conferenza telefonica componendo il numero (888) 596-4144 con l'ID conferenza 5872954, oppure unirsi tramite webcast nella sezione 'Eventi e Presentazioni' sul sito web di Penumbra. La registrazione del webcast rimarrà disponibile per almeno due settimane dopo la chiamata.
Penumbra (NYSE: PEN) ha programado la publicación de resultados del cuarto trimestre y del año completo 2024 para el 18 de febrero de 2025. La compañía emitirá un comunicado de prensa detallando los resultados financieros después del cierre del mercado, seguido de una conferencia telefónica a las 4:30 PM hora del Este.
Los inversores pueden acceder a la conferencia telefónica marcando el (888) 596-4144 con el ID de conferencia 5872954, o unirse mediante webcast a través de la sección 'Eventos y Presentaciones' en el sitio web de Penumbra. La grabación del webcast estará disponible durante al menos dos semanas después de la llamada.
펜엄브라 (NYSE: PEN)는 2024년 4분기 및 연간 실적 발표와 콘퍼런스 콜을 2025년 2월 18일로 예정했습니다. 회사는 시장 종료 후 재무 결과를 상세히 설명하는 보도자료를 발표한 후, 동부 표준시 기준 오후 4시 30분에 콘퍼런스 콜을 진행합니다.
투자자들은 (888) 596-4144로 전화하여 회의 ID 5872954로 콘퍼런스 콜에 접속할 수 있으며, 펜엄브라 웹사이트의 '이벤트 및 발표' 섹션을 통해 웹캐스트에 참여할 수 있습니다. 웹캐스트 녹화는 통화 후 최소 2주 동안 이용 가능합니다.
Penumbra (NYSE: PEN) a programmé la publication de ses résultats pour le quatrième trimestre et l'ensemble de l'année 2024 pour le 18 février 2025. L'entreprise publiera un communiqué de presse détaillant les résultats financiers après la clôture du marché, suivi d'une conférence téléphonique à 16h30, heure de l'Est.
Les investisseurs peuvent accéder à la conférence téléphonique en composant le (888) 596-4144 avec l'ID de conférence 5872954, ou rejoindre via le webcast dans la section 'Événements et présentations' du site web de Penumbra. L'enregistrement du webcast restera disponible pendant au moins deux semaines après l'appel.
Penumbra (NYSE: PEN) hat die Veröffentlichung seiner Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 auf den 18. Februar 2025 festgelegt. Das Unternehmen wird nach Börsenschluss eine Pressemitteilung mit den finanziellen Ergebnissen herausgeben, gefolgt von einer Telefonkonferenz um 16:30 Uhr Eastern Time.
Investoren können sich an der Telefonkonferenz beteiligen, indem sie (888) 596-4144 mit der Konferenz-ID 5872954 anrufen, oder über das Webcast in der Rubrik 'Events und Präsentationen' auf der Webseite von Penumbra teilnehmen. Die Aufzeichnung des Webcasts wird mindestens zwei Wochen nach dem Anruf verfügbar sein.
- None.
- None.
Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 5872954), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the completion of the call.
About Penumbra
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.
Investor Relations
Penumbra, Inc.
investors@penumbrainc.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-schedules-fourth-quarter-and-full-year-2024-earnings-release-and-conference-call-for-february-18-2025-302356557.html
SOURCE Penumbra, Inc.
FAQ
When will Penumbra (PEN) release its Q4 and full year 2024 earnings?
How can investors join Penumbra's (PEN) Q4 2024 earnings call?
What time is Penumbra's (PEN) Q4 2024 earnings conference call?
How long will Penumbra's (PEN) Q4 2024 earnings webcast be available?
